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Objective: Patients undergoing amputation of the lower limb due to peripheral arterial disease (PAD) are at risk of
developing deep venous thrombosis (DVT). Few studies in the research literature report the incidence of DVT during the
early postoperative period or the risk factors for the development of DVT in the amputation stump. This prospective
study evaluated the incidence of DVT during the first 35 postoperative days in patients who had undergone amputation
of the lower extremity due to PAD and its relation to comorbidities and death.
Methods: Between September 2004 and March 2006, 56 patients (29 men), with a mean age of 67.25 years, underwent 62
amputations, comprising 36 below knee amputations (BKA) and 26 above knee amputations (AKA). Echo-Doppler
scanning was performed preoperatively and on postoperative days 7 and 31 (approximately). All patients received
acetylsalicylic acid (100 mg daily) preoperatively and postoperatively, but none received prophylactic anticoagulation.
Results: DVT occurred in 25.8% of extremities with amputations (10 AKA and 6 BKA). The cumulative incidence in the
35-day postoperative period was 28% (Kaplan-Meier). There was a significant difference (P  .04) in the incidence of
DVT between AKA (37.5%) and BKA (21.2%). Age>70 years (48.9% vs 16.8%, P .021) was also a risk factor for DVT
in the univariate analysis. Of the 16 cases, 14 (87.5%) were diagnosed during outpatient care. The time to discharge after
amputation was averaged 6.11 days in-hospital stay (range, 1-56 days). One symptomatic nonfatal pulmonary embolism
occurred in a patient already diagnosed with DVT. There was no relation between other comorbidities and DVT. The
multivariate analysis showed no association between risk factors and the occurrence of DVT in the amputated extremity.
DVT ipsilateral to the amputation did not influence the mortality rate (9.7%).
Conclusion: The incidence of DVT in the early postoperative period (<35 days) was elevated principally in patients aged
>70 years and for AKA. Patients with PAD who have recently undergone major amputations should be considered at
high risk for DVT, even after hospital discharge. Given the high rate of postoperative DVT observed in this study, we now
recommend prophylactic anticoagulation for these patients, but further study is needed to determine the optimal
duration and efficacy of this treatment. (J Vasc Surg 2008;48:1514-9.)Although many studies have considered venous throm-
boembolism (VTE) in clinical and surgical patients, few
have focused on patients who have undergone amputation
of the lower extremities because of peripheral arterial dis-
ease (PAD). To our knowledge, no prospective research
studies with a sufficiently large amputee patient sample
have considered the incidence of deep venous thrombosis
(DVT) in the early postoperative period. Data from existing
studies are divergent, and the incidence of VTE is highly
variable, ranging from 0% to 66.66%.1,2 Amputation in-
volves considerable surgical trauma, including bone and
soft tissue dissection and division, and many surgeons do
not administer pharmacologic DVT prophylaxis because of
concerns about bleeding complications.
Studies of patients undergoing hip and knee prosthesis
procedures show a high incidence of DVT, not only in the
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1514early postoperative period but also up to 30 days after
surgery.3,4 Studies involving amputation of ischemic ex-
tremities have been limited to the hospitalization period
and provide no data on the occurrence of DVT after
discharge.5-10
In the present prospective study, we included patients
with PAD who underwent major amputation of the lower
extremity, and aimed to evaluate (1) the postoperative
incidence of DVT in the amputated extremity during hos-
pitalization and after discharge, (2) the relation between
comorbidities and DVT incidence, and (3) the relation of
DVT to symptomatic pulmonary embolism (PE) and oper-
ative mortality.
METHODS
A prospective and descriptive study of patients admit-
ted consecutively to the Emergency Department and the
Vascular Surgery Ward of the Clinics Hospital of the Fac-
ulty of Medicine of São Paulo University, Brazil, was con-
ducted from September 2004 through March 2006. The
study was reviewed and approved by the local Research
Ethics Committee.
The following variables were studied: age, sex, heart
disease, smoking, bedridden status, female hormone ther-
apy, obesity (body mass index 30 kg/m2), systemic arte-
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varicose veins of the lower extremities, paresthesia or para-
plegia of the limbs, malignancy, level of arterial occlusion,
secondary infection of the ischemic extremity, and recent
arterial revascularization surgery. We analyzed the associa-
tion between the incidence of VTE and the level of ampu-
tation, general medical postoperative complications, ampu-
tation stump complications, and postoperative mortality.
The accuracy of each patient’s history and clinical ex-
amination was tested, comparing the data with color-flow
Doppler findings, and checking clinical examination sensi-
tivity and specificity.
Duplex ultrasound (DUS) scanning was chosen as the
diagnostic method for DVT due to its noninvasive charac-
teristic and ability to provide reproducible results in re-
peated examinations,11 as well as its high sensitivity in
examining the proximal deep venous system of the lower
extremity.12-14 Patients underwent DUS imaging once be-
fore amputation and twice after surgery, between postop-
erative days 3 and 15, and between days 16 and 35.
All examinations were performed using a Logiq 5 ul-
trasound system (GE Healthcare, Milwaukee, Wisc). The
superficial femoral veins and common veins were examined,
as well as the popliteal vein and saphenofemoral junction,
for both lower extremities.15 B-mode was used to detect
intraluminal thrombi and vein compressibility, color mode
was used to evaluate flow, and Doppler spectral mode was
used for evaluation of the curve pattern. The examination
included the iliac veins whenever alteration in respiratory
flow phasicity was present in the common femoral vein. The
examination result was considered positive for DVT when
thrombus was identified and venous flow absent.12,13,16
All patients received acetylsalicylic acid (100 mg, daily)
preoperatively and postoperatively, but none received pro-
phylactic anticoagulation. Patients underwent stimulation
for early mobilization combined with motor and respira-
tory physical therapy, and were referred to an outpatient
rehabilitation center at discharge. Patients diagnosed with
DVT were treated with nonfractionated heparin or low-
molecular-weight heparin, followed by warfarin sodium for
a period of 6 months.14,17,18
All patients investigated in the study presented with
chronic arterial obstruction of the lower extremities, with
or without previous arterial revascularization, and were
indicated for above knee amputation (AKA) or below knee
amputation (BKA). Patients who received any type of anti-
coagulation therapy before surgery or who were unwilling
to participate in the study were not included. The treat-
ment regimen in patients excluded due to previous antico-
agulation was not discontinued.
Patients were excluded from the study if (1) DVT was
identified during the preoperative or intraoperative period
(all divided veins were assessed for the presence of intralu-
minal thrombi and the findings were reported by the sur-
geon), (2) the postoperative DUS scan was not performed
for any reason, (3) DVT was diagnosed only in the con-
tralateral extremity during the postoperative period, and(4) postoperative anticoagulation was administered for any
reason (treatment or prophylaxis).
Statistical analysis. The cumulative incidence of DVT
of the stump andmortality were determined by the Kaplan-
Meier method, with an accepted standard error of up to
0.1. Univariate analysis of the risk factors for DVT was
obtained by the log-rank test method, and Cox regression
was applied for multivariate analysis. Statistical significance
was set at P  .05.
RESULTS
During the study period, 82 patients with PAD under-
went 88 amputations. As summarized in Table I, 26 pa-
tients were excluded from the study; thus, 62 amputations
were studied in 56 patients, three of which were bilateral
amputations. In three other patients, a new proximal am-
putation was performed 30 days after the first surgery. The
mean age of the patients was 67.25  11.7 years (range,
43-88 years), and 51.7% were men. The prevalence of
associated diseases is listed in Table II. Of the 56 patients
studied, 37 (66.0 %) were unable to walk before amputa-
tion, and 12 (21.4%) were smokers.
Six patients had prior amputations of contralateral limbs
(4 BKA and 2 AKA), and two patients underwent bilateral
BKA in the same surgery. In all cases the primary indication for
amputation was critical limb ischemia associated with tissue
necrosis. In 76.7% there was also an associated local infection.
Eight patients (12.9%) had undergone an arterial revascular-
ization in the previous 30-day period.
The predominant location of obstructive arterial dis-
ease in the amputated limb was the femoropopliteal seg-
Table I. Patients excluded from the study and causes
(n  26)
Exclusion criteria No.
Pre-op presence of DVT 6
Intra-op diagnosis of DVT 2
Contralateral DVT in post-op period 2
No post-op echo-Doppler (due to lack of
conditions/death) 9
Post-op anticoagulant treatment 4
Complications of amputation stump with hip
disarticulation 1
Lost to follow-up 2
DVT, Deep venous thrombosis.
Table II. Prevalence of associated diseases (n  60)
Disease No. (%)
Systemic arterial hypertension 48 (80.0)
Diabetes mellitus 42 (70.0)
Heart disease 16 (26.7)
Varicose veins of lower limbs 14 (23.3)
Cerebral vascular accident 13 (21.7)
Obesity 7 (11.7)ment (71%). The prevalence of both iliofemoral and infra-
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amputation was BKA, in 36 (58.1%) cases. The left lower
extremity was the site of amputation in 51.6%. None of the
patients underwent knee disarticulation.
Mortality in the 30-day periodwas 9.7%.Most deaths had
well-established causes, except for one patient in which au-
topsy presented no specific diagnosis (no evidence of PE).
Medical complications occurred in 20.0% of the pa-
tients as follows: bronchopneumonia in 11.7%, peritonitis
and acute myocardial infarction in 3.3% each, and sepsis in
1.7%. One patient (1.6%) presented with a symptomatic
nonfatal PE. Amputation stump complications occurred in
45.3% of the amputations. In five cases of BKA, an early
(30 days) more proximal amputation was necessary.
During recovery, 16 cases of DVT were diagnosed in
the ipsilateral amputated extremity (Table III), 12 within
the first 15 days (75%) and four after this period. Of the 16
cases, 14 (87.5%) were diagnosed during outpatient care,
the average time to discharge after amputation was 6.11
days (range, 1-56 days). No iliac DVT was diagnosed, and
none of the patients who underwent bilateral amputation
had evidence of DVT. DVT also occurred in the contralat-
eral limb in three patients. The cumulative incidence of
DVT ipsilateral to the amputation was 24.4%30 days and
28.0% 35 days, with respective standard errors of 0.057
Fig 1. Cumulative incidence of venous thrombosis of the ampu-
tation stump by the Kaplan-Meier method. The arrowhead indi-
cates the average day of discharge after amputation.6,11
Table III. Diseased venous segment and level of
amputation
Venous segment
Amputation level
TotalAbove knee Below knee
Femoral 10 4 14
Popliteal 0 1 1
Femoropopliteal 0 1 1
Total 10 6 16and 0.064 (Fig 1).Clinical evaluation of the signs and symptoms of DVT
in the amputated limb had sensitivity of 56.2%, specificity
82.6%, negative-predictive value of 84.4%, and a positive-
Table IV. Univariate analysis of risk factors for deep
venous thrombosis of the amputation stump (log rank)
Factor No.
DVT per 100
individuals/d
Rate of
events P
Sex
Male 31 1.506 1 .13
Female 31 0.725 0.48
Arterial hypertension
Yes 50 1.063 0.95 .89
No 12 1.115 1
Diabetes mellitus
Yes 44 0.810 0.44 .09
No 18 1.837 1
Smokers
Yes 13 0.929 0.84 .69
No 49 1.112 1
Bedridden
Yes 39 0.819 0.53 .20
No 23 1.557 0
Amputation level
Thigh 26 1.792 1 .044
Leg 36 0.643 0.36
Age, y
69 36 0.590 0.28 .012
70 26 2.105 1
Side
Left 32 0.960 0.81 .55
Right 30 1.180 1
Obesity
Yes 8 0.885 0.62 .66
No 54 1.419 1
Ischemia/limb infection
Yes 48 1.025 0.83 .76
No 14 1.242 1
Reamputation
Yes 5 2.273 1 .66
No 57 1.036 0.46
Contralateral amputation
Yes 6 1.460 1 .67
No 56 1.033 0.71
Stroke
Yes 14 1.163 1 .94
No 48 1.045 0.90
Heart disease
Yes 17 1.626 1 .37
No 45 0.890 0.55
Revascularization
Yes 8 1.031 0.96 .99
No 54 1.078 1
Stump complications
Yes 27 1.250 1 .67
No 35 0.939 0.75
Clinical complications
Yes 11 0.725 0.63 .44
No 51 1.151 1
Death
Yes 6 3.278 1 .20
No 56 0.978 0.3
Varicose veins
Yes 15 1.312 1 .72
No 47 0.990 0.75
DVT, Deep venous thrombosis.predictive value of 52.9%.
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cant difference in the incidence of DVT ipsilateral to the
amputation when different levels were compared. AKA
presented a cumulative incidence of venous thrombosis of
37.5%, compared with 21.2% in patients who underwent
BKA, within the period up to day 35 after surgery (P .04;
Fig 2).
Patients aged70 years had significantly higher risk for
DVT in the amputated limb than younger patients within
the 35-day period (48.9% vs 16.8%, respectively; P .012;
Fig 3). The multivariate analysis showed no association
between risk factors and the occurrence of DVT in the
amputated extremity.
DISCUSSION
Analysis of the general patient characteristics revealed
Fig 2. Cumulative incidence by long-rank analysis of venous
thrombosis of amputation stump divided by amputation level
above knee (top line) and below knee (bottom line). The arrowhead
indicates the average day of discharge after amputation.6,11
Fig 3. Cumulative incidence by log-rank analysis of venous
thrombosis of the amputation stump divided by age70 years (top
line) and age 70 (bottom line). The arrowhead indicates the
average day of discharge after amputation.6,11no difference in the indications for amputation and com-plications in the amputated extremity with regard to previ-
ous related data.19-23 The most frequent site of chronic
arterial occlusion in this investigation was the superficial
femoral artery, in accordance with Roon et al.24 The per-
centage of patients who had undergone recent prior revas-
cularization of the amputated limb was within the limits
found in the literature.25-28 We also observed that the
concomitant bilateral amputations were in accordance with
other reports that stated values of 10.68% to 15%.23,29
Previous studies30,31 reported that failed BKA occurs in
approximately 15% of patients, similar to the incidence
observed in the present study. All new amputations to a
more proximal level were performed in the BKA group.
BKA failure was probably related to the surgery being
performed distal to a femoropopliteal obstruction (absence
of a palpable popliteal pulse) and close to an infection
source. Most patients had combined ischemia and local
infection preoperatively; these are contributing factors for
infection as the major cause of BKA complication (54.5%).
The occurrence of these complications and new amputa-
tion to a more proximal level did not influence the inci-
dence of DVT.
Previous studies report that the incidence of nonfatal
symptomatic PE varies from 2.1% to 8%.23,24 We believe
that the low incidence of symptomatic PE in the present
study was due to the diagnostic accuracy of the DUS series,
which resulted in immediate treatment of DVT and a
consequent decrease in the incidence of PE. Another pos-
sible reason was our choice not to investigate patients
without pulmonary symptoms. When diagnostic examina-
tions were performed for routine asymptomatic PE in pre-
vious studies, results varied from 11% to 14.28%.32,33 Al-
though the study by Williams et al34 attributed a PE risk
four times higher for amputations at the AKA level, we had
no cases of PE for AKA amputation in our study and only
one PE in a BKA.
Previous reports described perioperative mortality for
major amputation varying from 0% to 37%.24,35-37 We also
observed a mortality rate within this range. Univariate
statistical analysis revealed no relationship between DVT
and death. Nearly all DVT was diagnosed in the first 15
days after surgery, in agreement with previous studies,
independent of sample and methodology used.5-10
The patients who required amputation were not solely
at risk in the early postoperative period, they were also at
risk after hospital discharge. In this study, 87.5% of the
DVT diagnoses were made at the scheduled outpatient
return appointment for the postoperative DUS examina-
tion. This finding differs from that of others studies because
most researchers have studied the incidence of DVT only
during the hospitalization.1,2,5-7
A relationship was found between the type of ampu-
tation performed and the incidence of DVT. The high
incidence of DVT in patients who underwent AKA is
probably because the femoral vein is a conduction vessel
with few tributaries, a feature that leads to poor venous
flow in its remnant segments and consequent thrombo-
sis. Old age (70 years) was another factor related to
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observed in the distribution of AKA and BKA, or bed-
ridden individuals.
The presence of the other studied risk factors and
variables showed no relation to DVT ipsilateral to the
amputation, even after multivariate analysis; this finding is
in contrast to data from previous studies for clinical and
surgical patients in general.38-47 This discrepancy may re-
flect the relatively small number of patients in the present
study.
Yager et al5 demonstrated DVT risk factors to be
chronic venous insufficiency or previous history of DVT, or
both, and the presence of prior amputation of the contralat-
eral extremity. Their analysis also included patients diag-
nosed in the preoperative period (6 of 9, 66.7%) and in the
contralateral limb (4 of 9, 44.4%), and was conducted
using a methodology distinct from that used in our study,
in which we only considered postoperative cases of DVT in
the amputated extremity stump.
CONCLUSION
The incidence of DVT ipsilateral to the amputation is
elevated during the early postoperative period (35 days),
mainly in AKA and at ages of 70 years. There was no
relationship between the presence of the other comorbidi-
ties studied and postoperativeDVT occurrence. All patients
with PAD scheduled to undergo major amputation should
be considered at high risk for the development of DVT,
even during the period after discharge from the hospital.
On the basis of these results, we recommend prophylactic
anticoagulation (if not contraindicated) and surveillance to
all patients undergoing this type of procedure. Further
studies are required to determine the optimal method and
duration for prophylaxis treatment.
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